John Wofford, MD
Dermatopathology · Dallas, TXNPI 1245596451
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 393 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by AbbVie at 24.2% of the total.
Across 393 payments — averaging $27.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$1K
- Amgen$900
- Johnson & Johnson$823
- Regeneron Healthcare Solutions, Inc.$635
- LEO Pharma Inc.$603
- plus $4K from 29 others
What the payments were for
- Speaking & faculty fees$2082%
- Food & beverage$10,27996%
- Education$2032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 76 | $2,585 |
| Lilly USA, LLC | 47 | $1,184 |
| Amgen | 31 | $900 |
| Johnson & Johnson | 29 | $823 |
| Regeneron Healthcare Solutions, Inc. | 25 | $635 |
| LEO Pharma Inc. | 27 | $603 |
| E.r. Squibb & Sons, L.L.C. | 17 | $572 |
| Sun Pharmaceutical Industries Inc. | 20 | $556 |
| Sanofi | 15 | $426 |
| Galderma Laboratories, L.p. | 9 | $299 |
| Almirall LLC | 11 | $229 |
| UCB, Inc. | 10 | $224 |
| Incyte Corporation | 9 | $165 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $153 |
| Bristol Myers Squibb | 2 | $145 |
| Boehringer Ingelheim | 5 | $134 |
| Pfizer | 7 | $125 |
| Novartis | 5 | $113 |
| Mayne Pharma Commercial LLC | 8 | $110 |
| EPI Health, LLC | 5 | $107 |
| Arcutis Biotherapeutics, Inc. | 6 | $105 |
| Dermira, Inc. | 2 | $97 |
| Encore Dermatology Inc. | 4 | $81 |
| DUSA Pharmaceuticals, Inc. | 2 | $43 |
| VYNE Pharmaceuticals Inc. | 2 | $40 |
| Biofrontera Inc. | 2 | $38 |
| Merz North America, Inc. | 1 | $37 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Dermavant Sciences, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $19 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,691 in reported general payments places this provider in the 80th percentile of 54 dermatopathology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 12 | $253,807 |
| Taltz AutoinjectorIxekizumab | 16 | $111,993 |
| Clobetasol Propionate | 47 | $1,700 |
| Doxycycline Hyclate | 35 | $1,025 |
| Triamcinolone Acetonide | 89 | $990 |
| Ketoconazole | 63 | $988 |
| Mometasone Furoate | 55 | $889 |
| Dutasteride | 25 | $746 |
| Desonide | 11 | $504 |
| Minoxidil | 46 | $497 |
| Clindamycin Phosphate | 13 | $462 |
| ValacyclovirValacyclovir Hcl | 15 | $343 |
| Glycopyrrolate | 12 | $304 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Dallas
- Clay CockerellDallas$40K
- Titilola SodeDallas$11K
- Gregory HoslerDallas$3K
- Joseph SusaDallas$470
- Robert LawDallas$68
- Ryan HickDallas$50
- Angela MooreArlington$423K
- Melissa ChiangSpring$163K
- Alde GavinoLiberty Hill$110K
- Michael TetzlaffHoustion$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.